The Nishi-Shinjuku Illumination Market Lighting Ceremony, a New Illumination in Tokyo, Held to Illuminate the Nighttime in Nishi-Shinjuku!
11.12.2024 08:00:00 CET | Business Wire | Press release
The “TOKYO NIGHTTIME PROJECT” has been launched in the Nishi-Shinjuku area of Shinjuku-ku, Tokyo, with the aim of revitalizing night tourism. The project, by collaborating with organizations in the surrounding area, enlivens nighttime in Nishi-Shinjuku, an area where tradition and innovation intersect, with light displays and other activities to create a lively atmosphere for visitors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241203634601/en/
The Illuminations (Photo: Business Wire)
"Nishi-Shinjuku Illumination Market” started on November 28, 2024. On Chuo-dori Avenue along the Tokyo Metropolitan Government Building, approximately 200,000 champagne gold LED lights illuminate the street for as long as 200 meters, creating a fantastic night scene, a new illumination spot in Tokyo.
At the lighting ceremony, Judoka Hifumi Abe and Uta Abe, both from the Park24 club, appeared as guests. They pressed the light button following the countdown, and the street was enveloped in glittering champagne gold lights.
TOKYO NIGHTTIME PROJECT Overview
- Sponsor: Tokyo Nighttime Project Executive Committee
- Co-sponsor: Tokyo Metropolitan Government
-
Programs:
Nishi-Shinjuku Illumination Market
New Year's Eve countdown event "Happy New Year Tokyo 2025" - Dates: Thursday, November 28th, 2024 to Monday/National holiday, January 13th, 2025
-
TOKYO NIGHTTIME PROJECT official website
https://tokyo-nighttime-project.jp/en/ -
Nishi-Shinjuku Illumination Market Overview
In addition to the illumination, food trucks and markets will line up, selling foods and goods that give a sense of Edo culture. For details, please visit the event website https://tokyo-nighttime-project.jp/en/market/ -
New Year’s Eve Countdown event “Happy New Year Tokyo 2025” Overview
"Happy New Year Tokyo 2025” will be held on New Year's Eve to close the year, a countdown event for many people including the Tokyo residents and foreign visitors, to experience the charms of Tokyo and share the anticipation for the New Year together.
With the theme of tradition and innovation, which are the attractions of Tokyo, there will be projection mapping, live performances by Japanese drummers and DJs, and talk shows by guests. In addition, new year wishes by the participants will be projected in the form of digital ema (votive picture tablet).
For details, please visit the event website https://tokyo-nighttime-project.jp/en/countdown/
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241203634601/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Oticon Medical Introduces Ponto™ Instant, Expanding Non-Surgical Choice with Instant HearBand and Instant SoundConnector26.5.2026 07:00:00 CEST | Press release
Oticon Medical today announces its new non-surgical portfolio, Ponto Instant, designed to broaden access to bone conduction hearing and offer more choice for users and hearing care professionals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260525771593/en/ Left: Instant HearBand, a discreet behind-the-head wearable solution that offers an alternative to Softband 5. Right: Instant SoundConnector, a small accessory fitted to a cap or other headwear, providing another non-surgical way to wear a Ponto sound processor. The Ponto Instant portfolio includes Softband 5, Oticon Medical’s established and trusted non-surgical solution, and now expands with the launch of Instant HearBand and Instant SoundConnector, further strengthening its wearable offering for children and adults who prefer a non-surgical solution. Instant HearBand: a discreet new wearable alternative As part of the new portfolio, Instant HearBand is introduced as
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom